Breelyn A. Wilky, MD
机构: University of Colorado
每年引用次数
引用次数
引用: 2,562
H-指数: 25
I10-指数 : 47
出版物: 156
Prediction of Treatment Efficacy in Soft Tissue Sarcomas through Analysis of Habitat Heterogeneity in Mpmri
T. Diwanji , Y.C. Chang , T.K. Subhawong , B. Wilky
International Journal of Radiation Oncology Biology Physics 105 ( 1)
1
2019
Phase I safety and pharmacokinetic/pharmacodynamic results of the histone deacetylase inhibitor vorinostat in combination with bevacizumab in patients with kidney cancer
H. J. Hammers , H. Verheul , B. Wilky , B. Salumbides
Journal of Clinical Oncology 26 16094 -16094
10
2008
A precision medicine approach in sarcoma: identification of patients who may benefit from early use of pazopanib.
Gabriel Tinoco , Vaia Florou , Seyed Navid Alavi , Breelyn A Wilky
Discovery Medicine 25 ( 137) 131 -144
1
2018
Precision medicine in gastrointestinal stromal tumors.
Vaia Florou , Breelyn A Wilky , Jonathan C Trent
Discovery Medicine 28 ( 155) 267 -276
3
2019
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities
Alessandro Gronchi , Angelo P Dei Tos , Axel Le Cesne , George D Demetri
Cancer
50
2021
A nonrandom association of sarcoidosis in patients with gastrointestinal stromal tumor and other sarcomas
Andrea P Espejo , Jeremy L Ramdial , Breelyn A Wilky , Darcy A Kerr
Rare Tumors 10 2036361318787626
1
2018
High grade sarcoma presenting as multifocal recurrent seromas after inguinal hernia repair: A case report.
Lorne D Muir , Joshua D Woelfle , Jeffrey Schowinsky , Breelyn A Wilky
Rare Tumors 12 2036361320975746 -2036361320975746
2020
Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial.
Breelyn A Wilky , Matteo M Trucco , Ty K Subhawong , Vaia Florou
Lancet Oncology 20 ( 6) 837 -848
236
2019
Latest advances in adult gastrointestinal stromal tumors.
Vaia Florou , Breelyn A Wilky , Jonathan C Trent
Future Oncology 13 ( 24) 2183 -2193
3
2017
The current landscape of early drug development for patients with sarcoma in the immunotherapy era.
Ana Sebio , Breelyn A Wilky , Vicki L Keedy , Robin L Jones
Future Oncology 14 ( 12) 1197 -1211
7
2018
Much Ado about ASPS: The Rapidly Changing Treatment Paradigms of 2022
Breelyn A Wilky , Alessandra Maleddu
Clinical Cancer Research 29 ( 7) 1163 -1166
2023
Vimseltinib: a precision CSF1R therapy for tenosynovial giant cell tumors and diseases promoted by macrophages
Bryan D Smith , Michael D Kaufman , Scott C Wise , Yu Mi Ahn
Molecular cancer therapeutics 20 ( 11) 2098 -2109
15
2021
Emerging mechanisms of immunotherapy resistance in sarcomas
Vaia Florou , Breelyn A Wilky
Cancer Drug Resistance 5 ( 1) 199
2
2022
Real-world pan-cancer landscape of frameshift mutations (FSM) and their role in predicting responses to immune checkpoint inhibitors (ICI) in patients (pts) with tumors with low tumor mutational burden (TMB).
Vaia Florou , Charalampos S Floudas , Asaf Maoz , Abdul Rafeh Naqash
Journal of Clinical Oncology 39 ( 15_suppl) 2599 -2599
2021
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments
Silvia Stacchiotti , Anna Maria Frezza , George D Demetri , Jean-Yves Blay
Cancer treatment reviews 110 102455 -102455
12
2022
A phase 1 multiple-ascending dose study to evaluate the safety and tolerability of XmAb23104 (PD-1 x ICOS) in subjects with selected advanced solid tumors (DUET-3).
Mehmet Akce , Siwen Hu-Lieskovan , Matthew Reilley , James Fredric Strauss
Journal of Clinical Oncology 40 ( 16_suppl) 2604 -2604
5
2022
TGF-beta signal
Breelyn A Wilky , Matteo M Trucco , Ty K Subhawong , Vaia Florou
Dinaciclib inhibitor
Breelyn A Wilky , Matteo M Trucco , Ty K Subhawong , Vaia Florou
Peak study: A phase 3, randomized, open-label multi-center clinical study of bezuclastinib (CGT9486) and sunitinib combination versus sunitinib in patients with gastrointestinal stromal tumors (GIST).
William D Tap , Neeta Somaiah , Yoon-Koo Kang , Albiruni Ryan Abdul Razak
Journal of Clinical Oncology 42 ( 16_suppl) TPS11588 -TPS11588
2024
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial
Sandra P D'Angelo , Dejka M Araujo , Albiruni R Abdul Razak , Mark Agulnik
The Lancet 403 ( 10435) 1460 -1471
3
2024